Lynn A. Tetrault bought stock once, on May 9, 2025

Lynn A. Tetrault is a corporate director and former pharmaceutical executive who serves as a director of NeoGenomics Inc. (NEO), where she has held board roles since 2015, including Lead Independent Director, Non‑Executive Chair, Executive Chair, and Interim CEO.( As a NeoGenomics director, she continues to be an active corporate insider, recently trading company stock in June 2026.( In addition to her work with NeoGenomics, she is Non‑Executive Chairman of NeoGenomics, Inc., a board member of Rhythm Pharmaceuticals and Paradigm for Parity, and founder and principal of Anahata Leadership, an advisory firm focused on leadership development for senior women executives.(

Earlier in her career, Tetrault spent more than two decades at AstraZeneca PLC, ultimately serving as Executive Vice President of Human Resources and Corporate Affairs from 2007 to 2014 and becoming the first woman on the company’s senior executive team.( She began her professional career as a healthcare lawyer in private practice in Boston and went on to build a global leadership profile in the health care industry, including international roles across AstraZeneca’s US business and R&D operations.( Tetrault holds an undergraduate degree from Princeton University and a Juris Doctor from the University of Virginia School of Law.(

Written by Perplexity from public sources.